APA

Yao J., Caballero O. L., Huang Y., Lin C., Rimoldi D., Behren A., Cebon J. S., Hung M., Weinstein J. N., Strausberg R. L. & Zhao Q. (20170117). Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. : Cancer immunology research.

Chicago

Yao Jun, Caballero Otavia L, Huang Ying, Lin Calvin, Rimoldi Donata, Behren Andreas, Cebon Jonathan S, Hung Mien-Chie, Weinstein John N, Strausberg Robert L and Zhao Qi. 20170117. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. : Cancer immunology research.

Harvard

Yao J., Caballero O. L., Huang Y., Lin C., Rimoldi D., Behren A., Cebon J. S., Hung M., Weinstein J. N., Strausberg R. L. and Zhao Q. (20170117). Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. : Cancer immunology research.

MLA

Yao Jun, Caballero Otavia L, Huang Ying, Lin Calvin, Rimoldi Donata, Behren Andreas, Cebon Jonathan S, Hung Mien-Chie, Weinstein John N, Strausberg Robert L and Zhao Qi. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity. : Cancer immunology research. 20170117.